$0.37
0.72%
Nasdaq, Nov 28, 09:56 pm CET
ISIN
US1897631057
Symbol
CODX

Co-Diagnostics, Inc. Stock price

$0.37
-0.20 34.98% 1M
+0.08 27.79% 6M
-0.38 50.59% YTD
-0.57 60.42% 1Y
-2.75 88.12% 3Y
-11.35 96.84% 5Y
-5.44 93.62% 10Y
-5.44 93.62% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
-0.00 0.72%

Key metrics

Basic
Market capitalization
$22.6m
Enterprise Value
$11.1m
Net debt
positive
Cash
$11.4m
Shares outstanding
48.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
44.2 | 43.1
EV/Sales
21.8 | 21.3
EV/FCF
negative
P/B
0.6
Financial Health
Equity Ratio
84.9%
Return on Equity
-69.3%
ROCE
-86.6%
ROIC
-108.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$510.0k | $523.3k
EBITDA
$-34.3m | -
EBIT
$-35.5m | $-31.4m
Net Income
$-32.2m | $-36.1m
Free Cash Flow
$-31.8m
Growth (TTM | estimate)
Revenue
-93.0% | -86.7%
EBITDA
11.2% | -
EBIT
11.2% | 21.8%
Net Income
22.0% | 4.1%
Free Cash Flow
-18.5%
Margin (TTM | estimate)
Gross
34.0%
EBITDA
-6,760.0% | -
EBIT
-6,995.6%
Net
-6,336.2% | -6,897.3%
Free Cash Flow
-6,263.0%
More
EPS
$-0.8
FCF per Share
$-0.7
Short interest
3.0%
Employees
132
Rev per Employee
$30.0k
Show more

Is Co-Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Co-Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Co-Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
0.51 0.51
93% 93%
100%
- Direct Costs 0.34 0.34
91% 91%
67%
0.17 0.17
95% 95%
33%
- Selling and Administrative Expenses 16 16
21% 21%
3,071%
- Research and Development Expense 19 19
16% 16%
3,696%
-34 -34
11% 11%
-6,731%
- Depreciation and Amortization 1.20 1.20
10% 10%
235%
EBIT (Operating Income) EBIT -36 -36
11% 11%
-6,967%
Net Profit -32 -32
22% 22%
-6,310%

In millions USD.

Don't miss a Thing! We will send you all news about Co-Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Co-Diagnostics, Inc. Stock News

Neutral
PRNewsWire
11 days ago
SALT LAKE CITY , Nov. 20, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Company's Executive Vice President of Business Development, Joseph Featherstone, addressed a satellite session of the International Union Against...
Neutral
PRNewsWire
13 days ago
SALT LAKE CITY , Nov. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has begun clinical evaluations for its Co-Dx™ PCR Flu A/B, COVID-19, RSV Test Kit. The clinical performance testing is expected to support a submi...
Neutral
Seeking Alpha
17 days ago
Co-Diagnostics, Inc. ( CODX ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Andrew Benson - Head of Investor Relations Dwight Egan - Chairman & CEO Brian Brown - CFO & Company Secretary Conference Call Participants Michael Okunewitch - Maxim Group LLC, Research Division Presentation Operator Hello, and thank you for standing by. My name is Tiffany, and I will be your ...
More Co-Diagnostics, Inc. News

Company Profile

Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Dwight Egan
Employees 132
Founded 2013
Website codiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today